A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Stopped early · Phase 3

Conditions studied: Psoriasis

In brief

The main objective of this study is to evaluate the long-term safety of CP-690,550 in patients being treated for moderate to severe chronic plaque psoriasis. This is an open label extension study available to patients who participated in one of the qualifying studies with CP-690,550 providing entry criteria is met.

Key facts

Study ID

NCT01163253

Run by

Pfizer

People needed

2867

Starts

2010-09-01

Expected to finish

2016-06-01

Last updated by the study team

2017-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have participated in qualifying study with CP-690,550 and are 18 years or older with diagnosis of plaque-type psoriasis (psoriasis vulgaris).

You may not qualify if…

• Non-plaque or drug induced forms of psoriasis;
• Cannot discontinue current oral, injectable or topical therapy for psoriasis or cannot discontinue phototherapy (PUVA or UVB).
• Any uncontrolled significant medical condition.

Where it is running

• UAB Dermatology — Birmingham, Alabama, United States
• Horizon Research Group, Inc. — Mobile, Alabama, United States
• Radiant Research, Inc. — Tucson, Arizona, United States
• Burke Pharmaceutical Research — Hot Springs, Arkansas, United States
• Bakersfield Dermatology and Skin Cancer Medical Group — Bakersfield, California, United States
• Associates In Research, Inc. — Fresno, California, United States
• University of California Irvine — Irvine, California, United States
• Dermatology Research Associates — Los Angeles, California, United States
• Dermatology Specialists, Inc. — Oceanside, California, United States
• MedDerm Associates — San Diego, California, United States
• UCSD Dermatology — San Diego, California, United States
• University of California San Diego — San Diego, California, United States
• University of California San Francisco — San Francisco, California, United States
• Clinical Science Institute — Santa Monica, California, United States
• Healthcare Partners Medical Group — Torrance, California, United States
• Cherry Creek Research, Inc. — Denver, Colorado, United States
• The Savin Center, P.C. — New Haven, Connecticut, United States
• New England Research Associates, LLC — Trumbull, Connecticut, United States
• Florida Academic Dermatology Center — Coral Gables, Florida, United States
• North Florida Dermatology Associates, PA — Jacksonville, Florida, United States
• International Dermatology Research, Inc. — Miami, Florida, United States
• Renstar Medical Research — Ocala, Florida, United States
• Park Avenue Dermatology, PA — Orange Park, Florida, United States
• Leavitt Medical Associates of Florida dba Ameriderm Research — Ormond Beach, Florida, United States
• Radiant Research, Inc. — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.